HEALTH

DRJ continues sponsorship of Arthritis Foundation

BY Michael Johnsen

ENCINITAS, Calif. DRJ on Wednesday announced the renewal of its proceeds sponsorship of the Arthritis Foundation, where a percentage of each purchase of the company’s Stopain external analgesic is donated to the foundation.

“We see the mission of the Arthritis Foundation as a crucial health issue,” stated Bob Miller, VP sales and marketing for DRJ Group. “Our company mission is to help chronic pain sufferers manage their pain so they can lead richer, more active lives. We believe that working in cooperation with the Arthritis Foundation will help this become a reality.”

DRJ Group will make a minimum contribution of $25,000 for the coming year.

Earlier this year, DRJ Group’s support for the Arthritis Foundation began appearing on Stopain labels. The labels read, in part, “Your purchase benefits the Arthritis Foundation. For every unit of Stopain products sold, DRJ Group Inc. will donate a portion of the proceeds to the Arthritis Foundation with a minimum contribution of $25,000 to help people take control of arthritis.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Visine unveils new red eye formula

BY Allison Cerra

MORRIS PLAINS, N.J. Visine has developed a new eye-drop formula that relieves eye redness and irritation.

New Visine maximum redness relief formula uses a special Hydroblend formula to soothe irritation and provide up to ten hours of comfort, Visine said. In line with the product launch, Visine has developed a free app for iPhone and iPod Touch — the Visine red eye remover application — that eliminates red eye from consumers’ photos in moments.

Visine maximum redness relief formula is available nationwide for $5.99 (in 0.5 fl. oz.) at food, drug and mass merchandisers.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

House committee delays second hearing of McNeil recall probe

BY Michael Johnsen

WASHINGTON One day following the announcement of a second hearing regarding McNeil Consumer Healthcare recalls, the House Committee on Oversight and Government Reform on Tuesday announced the postponement of that second hearing in order “to examine the circumstances surrounding recalls of medicines recently recalled by Johnson & Johnson.”

Anew date has not been set.

Last week, McNeil Consumer Healthcare announced that four lots of Benadryl allergy ultratab tablets (100 count) and one lot of Extra Strength Tylenol rapid-release gels (50 count) would be added to its initial Jan. 15 product recall. This recall, McNeil said, is a follow-up to the product recall because the products were inadvertently omitted from the initial recall action.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES